TickerFacts.

Biolife Solutions Inc (BLFS): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$34.00M
As of 2025-12-31
$27.49M
As of 2026-06-30
-26.6%
3-year compound annual growth
$86.04M2010-12-31: $10.86M2011-12-31: $12.84M2012-12-31: $15.66M2013-12-31: $16.62M2014-12-31: $2.14M2015-12-31: $2.51M2016-12-31: $4.76M2017-12-31: $2.05M2018-03-31: $16.55M2018-06-30: $34.73M2018-09-30: $52.94M2018-12-31: $30.84M2019-03-31: $51.81M2019-06-30: $49.23M2019-09-30: $48.60M2019-12-31: $49.36M2020-12-31: $29.58M2021-12-31: $76.24M2022-12-31: $86.04M2023-12-31: $75.05M2024-12-31: $50.58M2025-12-31: $34.00M$34.00M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$34.00M-32.8%2026-02-26, Balance as of period end
2024-12-31$50.58M-32.6%2026-02-26, Balance as of period end
2023-12-31$75.05M-12.8%2025-03-03, Balance as of period end
2022-12-31$86.04M+12.9%2024-02-29, Balance as of period end
2021-12-31$76.24Mn/c2023-03-31, Balance as of period end
2020-12-31$29.58M-40.1%2022-03-31, Balance as of period end
2019-12-31$49.36Mn/a2021-03-31, Balance as of period end
2019-09-30$48.60Mn/a2020-05-15, Balance as of period end
2019-06-30$49.23Mn/a2020-05-15, Balance as of period end
2019-03-31$51.81Mn/a2020-05-15, Balance as of period end
2018-12-31$30.84Mn/a2020-05-15, Balance as of period end
2018-09-30$52.94Mn/a2020-05-15, Balance as of period end
2018-06-30$34.73Mn/a2020-05-15, Balance as of period end
2018-03-31$16.55Mn/a2020-05-15, Balance as of period end
2017-12-31$2.05M-56.9%2019-03-15, Balance as of period end
2016-12-31$4.76M+89.6%2018-03-09, Balance as of period end
2015-12-31$2.51M+17.5%2017-03-15, Balance as of period end
2014-12-31$2.14M-87.1%2016-02-25, Balance as of period end
2013-12-31$16.62M+6.2%2015-03-12, Balance as of period end
2012-12-31$15.66M+21.9%2014-02-12, Balance as of period end
2011-12-31$12.84M+18.3%2013-03-29, Balance as of period end
2010-12-31$10.86Mn/a2012-03-29, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Biolife Solutions Inc (BLFS)2025-12-31$34.00M-32.8%
Ceribell, Inc. (CBLL)2025-12-31$40.47M+18.2%
Outset Medical, Inc. (OM)2025-12-31$137.54M-44.8%
Electromed, Inc. (ELMD)2026-06-30$12.29M+16.0%
Iridex Corp (IRIX)2026-01-03$24.23M-10.4%
Axogen, Inc. (AXGN)2025-12-31$92.84M-7.0%
Stereotaxis, Inc. (STXS)2025-12-31$33.53M-5.0%
electroCore, Inc. (ECOR)2025-12-31$20.38M+57.6%
InMode Ltd. (INMD)2025-12-31$83.23M+1.7%

Compare BLFS, CBLL, OM, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗